We are live on ! Find out more
BHCM

Brevan Howard Capital Management Portfolio holdings

AUM $13.5B
1-Year Est. Return 44.56%
This Fund
S&P 500
This Quarter Est. Return
-1.5%
1 Year Est. Return
+44.56%
3 Year Est. Return
+147.62%
5 Year Est. Return
+116.32%
10 Year Est. Return
–
AUM
$11.3B
AUM Growth
+$2.15B
Cap. Flow
+$5.61B
Cap. Flow %
49.58%
Top 10 Hldgs %
40.26%
Holding
2,593
New
888
Increased
644
Reduced
565
Closed
479

Top Buys

Rank Stock Value
1
QQQ icon
Invesco QQQ Trust
QQQ
+$887M
2
IBIT icon
iShares Bitcoin Trust
IBIT
+$812M
3
MSFT icon
Microsoft
MSFT
+$670M
4
HYG icon
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
+$516M
5
NVDA icon
NVIDIA
NVDA
+$451M

Top Sells

Rank Stock Value
1
FTKI
First Trust Small Cap BuyWrite Income ETF
FTKI
+$452M
2
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$147M
3
GOOG icon
Alphabet (Google) Class C
GOOG
+$135M
4
IVV icon
iShares Core S&P 500 ETF
IVV
+$112M
5
WMT icon
Walmart Inc
WMT
+$89.8M

Sector Composition

Rank Sector Weight
1 Miscellaneous 47.58%
2 Technology 13.8%
3 Consumer Discretionary 10.24%
4 Financials 7.64%
5 Industrials 5.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GCMG icon
1926
GCM Grosvenor
GCMG
$839M
$167K ﹤0.01%
17,049
-76,709
-82% -$850K
DSGN icon
1927
Design Therapeutics
DSGN
$946M
$163K ﹤0.01%
+15,294
New +$155K
AIFC
1928
AI Financial Corp
AIFC
$83.1M
$162K ﹤0.01%
+145,960
New +$238K
MRAM icon
1929
Everspin Technologies
MRAM
$403M
$162K ﹤0.01%
+18,415
New +$203K
KROS icon
1930
Keros Therapeutics
KROS
$219M
$162K ﹤0.01%
+14,651
New +$226K
MATV icon
1931
Mativ Holdings
MATV
$669M
$161K ﹤0.01%
18,469
+1,071
+6% +$12.3K
ACHV icon
1932
Achieve Life Sciences
ACHV
$834M
$160K ﹤0.01%
+54,508
New +$242K
CLNE icon
1933
Clean Energy Fuels
CLNE
$359M
$160K ﹤0.01%
64,367
+36,179
+128% +$84.3K
ALXO icon
1934
ALX Oncology
ALXO
$277M
$159K ﹤0.01%
+79,389
New +$151K
FC icon
1935
Franklin Covey
FC
$230M
$159K ﹤0.01%
+10,044
New +$165K
RGNX icon
1936
Regenxbio
RGNX
$638M
$158K ﹤0.01%
18,902
+2,062
+12% +$21.7K
NMFC icon
1937
New Mountain Finance
NMFC
$712M
$158K ﹤0.01%
+20,367
New +$170K
VMET
1938
Versamet Royalties Corp
VMET
$1.11B
$158K ﹤0.01%
+16,603
New +$171K
GENB
1939
CALL
Generate Biomedicines
GENB
$1.97B
$157K ﹤0.01%
+12,571
New +$153K
OBIO icon
1940
Orchestra BioMed
OBIO
$311M
$156K ﹤0.01%
+36,769
New +$157K
EGAN icon
1941
eGain
EGAN
$203M
$156K ﹤0.01%
+19,764
New +$191K
MSDL icon
1942
Morgan Stanley Direct Lending Fund
MSDL
$1.28B
$155K ﹤0.01%
+11,115
New +$172K
VMD icon
1943
Viemed Healthcare
VMD
$336M
$155K ﹤0.01%
+16,823
New +$140K
TYGO icon
1944
Tigo Energy
TYGO
$83.7M
$155K ﹤0.01%
+41,158
New +$136K
VSTS icon
1945
Vestis
VSTS
$1.65B
$154K ﹤0.01%
19,637
-9,536
-33% -$69.7K
JBI icon
1946
CALL
Janus International
JBI
$667M
$153K ﹤0.01%
+29,762
New +$193K
VERI icon
1947
Veritone
VERI
$80.2M
$153K ﹤0.01%
+77,548
New +$262K
ORN icon
1948
Orion Group Holdings
ORN
$375M
$152K ﹤0.01%
13,977
-3,800
-21% -$45.5K
ALLO icon
1949
Allogene Therapeutics
ALLO
$698M
$152K ﹤0.01%
62,406
-8,023
-11% -$16.1K
SANA icon
1950
Sana Biotechnology
SANA
$1.18B
$152K ﹤0.01%
52,810
-17,797
-25% -$70.1K
76 77
78
79 80

Similar funds

MGIA
Moneta Group Investment Advisors St Louis, Missouri $13.5B AUM 24.62% 1-Year Est. Return
PMAM
Picton Mahoney Asset Management Toronto, Ontario, Canada $13.5B AUM 51.46% 1-Year Est. Return
DWM
Dynasty Wealth Management St. Petersburg, Florida $13.5B AUM 21.55% 1-Year Est. Return
BGC
Beutel, Goodman & Co Toronto, Ontario, Canada $13.6B AUM 17.82% 1-Year Est. Return
VIA
Vantagepoint Investment Advisers Washington, District of Columbia $13.4B AUM 22.25% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $13.6B AUM 7.6% 1-Year Est. Return
MSV
MN Services Vermogensbeheer The Hague, Netherlands $13.4B AUM 47.26% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return

Brevan Howard Capital Management's Q1 2026 Portfolio in Review

As of Q1 2026, Brevan Howard Capital Management held 2,593 positions worth $11.3B, up 23% from $9.16B the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Brevan Howard Capital Management deployed $5.61B of net new capital in Q1 2026, opening 888 new positions and adding to 644 existing holdings. Its largest new stake was iShares iBoxx $ High Yield Corporate Bond ETF: 6,420,000 shares worth $511M.

By sector, the portfolio is most concentrated in Miscellaneous at 48% of assets, down from 58% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Alphabet (Google) Class A, an estimated $147M trimmed.

  • Brevan Howard Capital Management's largest Q1 2026 buy was iShares iBoxx $ High Yield Corporate Bond ETF: 6,420,000 shares worth $511M.
  • Brevan Howard Capital Management added most to Invesco QQQ Trust in Q1 2026, an estimated $887M increase.
  • Brevan Howard Capital Management's biggest Q1 2026 reduction was Alphabet (Google) Class A, cutting an estimated $147M.
  • Brevan Howard Capital Management fully exited First Trust Small Cap BuyWrite Income ETF in Q1 2026, selling an estimated $452M.
  • Brevan Howard Capital Management's ten largest holdings make up 40% of its $11.3B portfolio in Q1 2026.
  • Brevan Howard Capital Management opened 888 new positions and closed 479 in Q1 2026.
  • Brevan Howard Capital Management's portfolio value rose 23% quarter-over-quarter to $11.3B.

Based on Brevan Howard Capital Management's 13F filing for Q1 2026, filed 15 May 2026.